Работы, цитирующие эту работу

Работ: 2

Работа: Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

1. Cerebrospinal fluid biomarkers in Alzheimer's disease: enhancing diagnostic precision and guiding therapeutic strategies

   Askarov Pulat Azadovich, Behruz Oralov, Kenjayev Sherzod +10

   СтатьяDementia and Cognitive Impairment ResearchClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.012361

2. Bridging the gaps in Alzheimer's disease biomarker research: From multi-omics integration to point-of-care diagnostics, a comprehensive review

   Shakhboz Khasanov, Mansur Tolibov, Nigora Daminova

   СтатьяAlzheimer's disease research and treatmentsClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.014009